About MUSC Hollings Cancer Center
Groundbreaking research to save lives
Our mission at MUSC Hollings Cancer Center is to eradicate cancer. It’s a bold mission, we know. We also know the toll cancer takes each year on our state’s residents. There will be an estimated 33,440 cases in 2022, with almost 11,000 deaths.
Hollings Cancer Center is the only National Cancer Institute-designated cancer center in the state. As the largest academic-based cancer research program in South Carolina, we are at the forefront of cancer research. We are also part of a network of 71 designated centers across the nation collaborating to accelerate scientific discoveries and offer cancer patients more and better treatment options.
With more than 120 cancer scientists across 20 different academic departments, Hollings provides a collaborative research environment focused on the causes, prevention, and treatment of cancer. We have experts known nationwide in a wide variety of fields from immunotherapy to health disparities. Hollings has an annual research funding portfolio of more than $44 million and more than 200 clinical trials so that this research gets into the clinics to help cancer patients.
Providing quality, patient-centered care is part of our mission
It’s one reason MUSC Health was named one of the top hospitals for the treatment of cancer in U.S. News & World Report, ranking at #39 in the nation this year. We have an award-winning bone marrow and stem cell transplantation program, and MUSC’s new Shawn Jenkins Children’s Hospital has a floor dedicated to cancer care for children.
I love the fact that we are able to cycle and pedal to raise dollars for cancer research and really make a difference in cancer care. We are trying to get more people on the bike and impact the community and ride with us for this very important effort. Together we can make a difference in cancer care.